Zacytuj

1. RIJKEN D.C., LIJNEN H.R. New insights into the molecular mechanisms of the fibrinolytic system. J ThrombHaemost. 2009;7(1):4-13.10.1111/j.1538-7836.2008.03220.xSearch in Google Scholar

2. TRIPODI A., MANNUCCI P.M. The coagulopathy of chronic liver disease. N Engl J Med. 2011; 365(2):147-56.10.1056/NEJMra1011170Search in Google Scholar

3. LEEBEEK F.W., RIJKEN D.C. The fibrinolytic status in liver diseases. Semin Thromb Hemost. 2015 Jul; 41(5):474-80.10.1055/s-0035-1550437Search in Google Scholar

4. NAINA H.V.K., PATNAIK M.M., ALI U.A., CHEN D., ASHRANI A.A. Systemic fibrinolysis caused by tissue plasminogen activator-producing metastatic breast cancer. J Clin Oncol. 2010; 28(11):3167-8.10.1200/JCO.2009.25.2502Search in Google Scholar

5. OKAJIMA K., KOHNO I., SOE G. Direct evidence for systemic fibrinogenolysis is in patients with acquired alpha 2-plasmin inhibitor deficiency. Am J Hematol 1994; 45:16.10.1002/ajh.2830450104Search in Google Scholar

eISSN:
2501-062X
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Medicine, Clinical Medicine, Internal Medicine, other, Cardiology, Gastroenterology, Rheumatology